DeutschNewstral
Article
bizjournals.com on 2017-03-16 16:12
Court allows Allergan shareholders to go after Ackman, Valeant as a class
Related news
Bill Ackman And Valeant Settle Allergan Insider Trading Lawsuit For $290 MillionForbes
Valeant Rout Vindicates Allergan Directorswsj.com- FAckman lifts Valeant stake as shares diveft.com
- FAckman agrees $194m settlement over Allergan suitft.com
Bill Ackman can’t escape Valeant lawsuitNew York Post- Judge Sides Against Ackman and Valeant in Preliminary Allergan Rulingwsj.com
- Why Allergan Shareholders Love Bad Newswsj.com
How much is Bill Ackman running the new Valeant?business.financialpost.com- Bill Ackman Is Playing Valeant Again And This Time He Owns The StockForbes
- MAckman parts company with key player behind his investment in Valeantmarketwatch.com
Valeant CEO to resign as activist investor Ackman takes seat on boardCBC- FAlphachat: Pharma madness (Valeant, Pfizer-Allergan), and a few Angus Deaton clipsftalphaville.ft.com
- SChemical Peel Market Excellent Growth 2020 Top Key Players | Allergan, Merz Pharma, Valeant, Galdermastoutonia-online.com
- Judge Signals He Will Approve Settlement Between Allergan Shareholders and Pershing, Valeantwsj.com
- FAckman ditches disastrous Valeant investmentft.com
- Ackman, Sequoia Stock Valeant Changes CourseForbes
- MAckman reduces Valeant stake, cites taxesmarketwatch.com
- FAckman admits fault in Valeant investmentft.com
- FAckman bails out on disastrous Valeant investmentft.com
- FAckman parts ways with Valeant advocateft.com